This hypothesis is evidenced by the animal study that G9a inhibitor in combination with GEM reduces IL-8 production and decreases tumor growth, lymph node invasion and distant metastasis of GEM-resistant cancer cells. The gene discussed is EHMT2; the disease is cancer.